Oncocyte Appoints Gisela A. Paulsen as Chief Operating Officer
07 oct. 2021 08h00 HE
|
Oncocyte Corporation
IRVINE, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear...
Oncocyte Publishes Study Demonstrating Predictive Potential for DetermaIO® Test in Triple Negative Breast Cancer
30 sept. 2021 08h00 HE
|
Oncocyte Corporation
IRVINE, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear...
Oncocyte Announces Oral Presentation of New Data on Its DetermaIO™ Immunotherapy Response Test at the European Society for Medical Oncology Annual Meeting
20 sept. 2021 11h35 HE
|
Oncocyte Corporation
Randomized clinical trial data from NeoTRIPaPDL1 study establishes DetermaIO as a predictive biomarker of immunotherapy response Trial Investigators found DetermaIO outperformed 80 other immune...
Oncocyte Hosting Two-Part Key Opinion Leader Event Series
20 sept. 2021 08h00 HE
|
Oncocyte Corporation
Part 1: Transplant Rejection Testing – Wednesday, September 22nd @ 1pmET Part 2: DetermaIO™ in Triple-Negative Breast Cancer – Tuesday, September 28th @ 1pmET IRVINE, Calif., Sept. 20, 2021 (GLOBE...
Modern Healthcare Recognizes Oncocyte as One of the 2021 Best Places to Work in Healthcare
16 sept. 2021 08h00 HE
|
Oncocyte Corporation
CHICAGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear...
Oncocyte to Present New Data on DetermaIO™ from NeoTRIPaPDL1 Trial in Oral Presentation from Late-Breaking Abstract at ESMO 2021
13 sept. 2021 08h00 HE
|
Oncocyte Corporation
IRVINE, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear...
Oncocyte to Participate in the 5th Annual Lake Street Capital Markets Best Ideas Growth Conference
07 sept. 2021 16h05 HE
|
Oncocyte Corporation
IRVINE, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear...
Oncocyte Launches First Real-World Evidence (RWE) Registry to Evaluate Biomarker Impact on Early-Stage Lung Cancer Treatment Decisions and Outcomes
17 août 2021 08h00 HE
|
Oncocyte Corporation
Predictive Assay for Decision Making in Adjuvant Therapy (PADMA) Registry to enroll more than 1,000 patients at 25 major hospitals treating lung cancer in the United States beginning Q4 2021 ...
Oncocyte Reports Second Quarter 2021 Financial Results and Provides Corporate Update
10 août 2021 16h01 HE
|
Oncocyte Corporation
DetermaRx Q2 Sample Volume Grows 23% over Q1 2021 Potential pan-cancer utility of DetermaIO strengthened by data in breast, lung, bladder and renal cell cancer, validating the test in all four tumor...
Oncocyte to Participate in Upcoming Investor Events
09 août 2021 08h00 HE
|
Oncocyte Corporation
IRVINE, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear...